This session is part of a multi-session and multi-disciplinary series that will provide prosecutors, law enforcement officers and toxicologists a background to Drug DUI Cases. This series is intended to provide a background to the DRE Program and the many different drug categories that one may encounter in a Drug DUI Case. These sessions are designed to provide extensive background as to the common observable signs and effects of each drug category to allow for better investigation and prosecution of Drug DUI Cases. To better achieve this goal, this series is multi-disciplinary in that each DRE Drug Category will first be explained from the DRE Law Enforcement perspective, and then the following week from the Toxicologist perspective. In such a way, prosecutors, law enforcement officers and toxicologists will all get an idea as to how each discipline is able to present evidence and testimony in a Drug DUI Case. Sessions will go into details about effects, duration, ingestion, and other information about each individual category from both a Law Enforcement and a Toxicology perspective so that such categories can be better documented by law enforcement and be better explained to a jury by prosecutors, law enforcement officers and toxicologists. By the end of this series, prosecutors, law enforcement officers and toxicologists should be able to better handle the many difficult aspects of Drug DUI cases and understand the complimentary roles of DREs and Toxicologists. This specific session will focus on CNS Stimulants from the Toxicologist perspective. 

**Note, this series is NOT a substitute for either the formal ARIDE or DRE Training and it will NOT allow law enforcement officers to testify as Expert Witnesses regarding any of the Drug Categories discussed or to make any specific conclusions as to Drug Category**

This session is designed for Prosecutors, Agency Legal Advisors and any LEO or Toxicologist that deals with DUI/Traffic Enforcement. 

Please share with whoever you feel appropriate, and remember that this session will be recorded if you are unable to attend at the live session, just please make sure to register to receive a link to the recording.

Session Information

Date:

Wednesday, February 5, 2025

Time:

1p-2p Eastern

Presenter:

Kelly Bugden, M.S., D-ABFT-FT

   Crime Laboratory Analyst – Toxicology

   Florida Department of Law Enforcement

Click to Register - CNS Stimulants Part 2



There is NO CHARGE to attend this webinar, however you must register in advance using the link listed above. After registering you will receive a confirmation email containing instructions on how to join the webinar. Please make sure you retain the confirmation email sent to you and be careful to enter your email address correctly; you will not be able to join the webinar if you do not receive a confirmation email. 

If you will be unable to attend this webinar at the scheduled time but would still like to watch, please go ahead and register as everyone who is registered will receive a link to the recording of the webinar regardless of whether they attended.

SAVE THE DATE: UPCOMING WEBINAR WEDNESDAY SESSIONS

• February 19, 2025 -- The Effect of Drugs in a DUI-D Case: Hallucinogens, Part 1 - The DRE

Click to Register - Hallucinogens, Part 1 - The DRE

• February 26, 2025 -- The Effect of Drugs in a DUI-D Case: Hallucinogens, Part 2 - The Toxicologist

Click to Register - Hallucinogens, Part 2 - The Toxicologist

• March 5, 2025 -- The Effect of Drugs in a DUI-D Case: Dissociative Anesthetics, Part 1 - The DRE

Click to Register - Dissociative Anesthetics, Part 1 - The DRE

• March 13, 2025 -- The Effect of Drugs in a DUI-D Case: Dissociative Anesthetics, Part 2 - The Toxicologist

Click to Register - Dissociative Anesthetics, Part 2 - The Toxicologist

• March 19, 2025 -- The Effect of Drugs in a DUI-D Case: Narcotic Analgesics, Part 1 - The DRE

Click to Register - Narcotic Analgesics, Part 1 - The DRE

• March 26, 2025 -- The Effect of Drugs in a DUI-D Case: Narcotic Analgesics, Part 2 - The Toxicologist

Click to Register - Narcotic Analgesics, Part 2 - The Toxicologist

• April 2, 2025 -- The Effect of Drugs in a DUI-D Case: Inhalants, Part 1 - The DRE

Click to Register - Inhalants, Part 1 - The DRE

• April 8, 2025 -- The Effect of Drugs in a DUI-D Case: Inhalants, Part 2 - The Toxicologist

Click to Register - Inhalants, Part 2 - The Toxicologist

• April 23, 2025 -- The Effect of Drugs in a DUI-D Case: Cannabis, Part 1 - The DRE

Click to Register - Cannabis, Part 1 - The DRE

• April 30, 2025 -- The Effect of Drugs in a DUI-D Case: Cannabis, Part 2 - The Toxicologist

Click to Register - Cannabis, Part 2 - The Toxicologist

• May 7, 2025 -- The Effect of Drugs in a DUI-D Case: Poly-Drug Use, Part 1 - The DRE

Click to Register - Poly-Drug Use, Part 1 - The DRE

• May 14, 2025 -- The Effect of Drugs in a DUI-D Case: Poly-Drug Use, Part 2 - The Toxicologist

Click to Register - Poly-Drug Use, Part 2 - The Toxicologist

• May 28, 2025 -- DRE Testimony: What a DRE Officer Can Do for Your Next Drugged Driving Trial

Click to Register - DRE Testimony

• June 4, 2025 -- Beyond the Beaker: Toxicology Standards & Tech on Trial

Click to Register - Toxicology Testimony

• June 18, 2025 -- Windows On Impairment: The Eyes Say It All

Click to Register - Windows On Impairment: The Eyes Say It All

• June 25, 2025 -- Decoding SFST & DRE Illusory Correlations – Polishing Our Capability & Proficiency

Click to Register - Decoding SFST & DRE Illusory Correlations

• July 9, 2025 -- SFST Evidence in Drug DUI Cases

Click to Register - SFST Evidence in Drug DUI Cases

If you have any questions or need any assistance registering for the webinar, please feel free to contact Florida TSRP Vin Petty at VinPetty@FloridaTSRP.com

This webinar is being conducted by the Florida TSRP Program utilizing the

National TSRP Program webinar account. The account is funded through the

NAPC/NHTSA Cooperative Agreement, Project Number 693JJ92050011